Enhancing CMS Stars Performance at Green Valley Care

Current Performance Overview

Green Valley Care operates two Medicare Advantage payer relationships with meaningfully different Stars profiles. Payer B leads with an overall score of 23 against Payer A's 21 — a gap driven largely by performance differences in the most heavily weighted measures.

Across four key measures, the picture breaks down as follows:

• Breast Cancer Screening (BCS) — Both payers achieve 5 Stars (Payer A: 83%, Payer B: 88%). A shared strength and consistent high point.
• Controlling Blood Pressure (CBP) — Both payers sit at 3 Stars (Payer A: 67%, Payer B: 68%). The lowest-rated measure for both — and the most consequential shared gap.
• Medication Adherence for Diabetes (DDM) — Payer B holds 4 Stars (90%); Payer A is at 3 Stars (89%). A single percentage point separates Payer A from a star jump on a measure weighted 3x.
• Care for Older Adults — Pain Screening (COA-PNS) — Payer A leads at 4 Stars (77%); Payer B trails at 3 Stars (74%). Payer B is one point from matching Payer A here.

Priority Areas for Intervention

Controlling Blood Pressure (CBP) — Both Payers

CBP is the most urgent shared gap. At 3 Stars for both payers, it represents a fundamental clinical outcome measure with high weight in the Stars calculation. The interventions are well-established: enhanced patient education on blood pressure management, structured follow-up protocols for uncontrolled patients, home blood pressure monitoring programs, and community health worker outreach. The shared nature of the gap makes it the best candidate for a coordinated, cross-payer "CBP Blitz" program — pooling resources and standardizing the workflow rather than running parallel efforts.

Medication Adherence for Diabetes (DDM) — Payer A

Payer A sits at 89% compliance — one point below the 4-star cut-point, on a measure weighted three times higher than standard measures. The math here is unusually clear: a 1% compliance improvement for Payer A produces a disproportionate score gain. Interventions should focus on patient-specific medication reconciliation, pharmacist-led adherence counseling, and automated refill reminders. Real-time provider alerts when patients approach non-adherence risk are particularly valuable given the narrow margin involved.

Care for Older Adults — Pain Screening (COA-PNS) — Payer B

Payer B is at 74% — one point below the 4-star threshold for COA-PNS. Rather than designing a new intervention from scratch, the right move is to analyze what Payer A's markets are doing to sustain 77% and systematically replicate those workflows in Payer B's underperforming markets. Sharing documentation practices, patient communication scripts, and scheduling protocols across payer markets is a faster path to improvement than external benchmarking.

Data Requirements for Targeted Action

Effective Stars improvement requires more than measure-level compliance data. Three additional data layers materially sharpen intervention design:

Operational data — workflow maps for each low-performing measure, staffing and training gaps, EHR utilization patterns that might be suppressing documentation compliance.

Patient population data — demographic and socioeconomic breakdowns to identify which patient cohorts face structural barriers to adherence or screening. Surveys and focus groups on patient-reported obstacles are underused in this space and often surface faster wins than analytics alone.

Stars program data — three to five years of historical trends to identify whether gaps are structural or cyclical, and a deep review of CMS technical specifications to understand the precise calculation methodology for each measure and where documentation practices may be inadvertently leaving compliant care uncounted.

Measuring and Communicating Progress

Stars improvement programs succeed or fail on accountability infrastructure as much as clinical intervention. Four mechanisms anchor the reporting framework:

Monthly Stars dashboards — current compliance rates, simulated Star rating projections, and market-level drill-downs for leadership and payer-specific teams.

Quarterly Stars review meetings — trend analysis, initiative effectiveness reviews, and strategic adjustments with executive leadership and the Stars committee.

Internal communications — a Stars newsletter or periodic updates for all staff, celebrating measure improvements and sharing best practices. The Stars program is only as strong as front-line buy-in, and front-line staff rarely see the connection between their daily documentation and the plan's quality rating.

Ad-hoc deep dives — collaborative problem-solving sessions for teams or markets struggling with specific measures, using granular data to identify root causes rather than defaulting to generic interventions.

Key Takeaways

The data tells a concentrated story: CBP is the shared gap that demands coordinated action across both payers; DDM is the highest-leverage opportunity for Payer A given the narrow margin and heavy weighting; COA-PNS for Payer B is a knowledge transfer problem more than a clinical one. All three are winnable with focused, data-driven intervention — and none require major structural change. The constraint is execution discipline and the quality of the accountability systems sitting behind the work.